Navigation Links
Uroplasty Plans to Double Sales Force During Fiscal 2009
Date:4/3/2008

MINNEAPOLIS, April 3, 2008 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunction, today announced plans to double its U.S. sales force by the end of its fiscal 2009, which began on April 1, 2008.

"We have successfully launched our second generation Urgent PC(R) neuromodulation system in the U.S. and in fiscal 2008 built a domestic sales force that has generated significant year-to-date sales growth," said David Kaysen, President and CEO. "As a result of this strong performance, and with the opportunity to continue our revenue growth during fiscal 2009, we plan to double the number of U.S. sales representatives to 36 from a team of 18 employed as of March 31, 2008."

"Most of the additions to the sales team are expected to be in place during the first half of our fiscal 2009," Mr. Kaysen continued. "With this planned expansion, we project U.S. revenues to increase by more than 70% during fiscal 2009, with most of the impact from the new team members coming in the fourth fiscal quarter given the approximate six-month ramp we believe necessary for the new sales representatives to gain experience and build customer relationships. In the first fiscal quarter, we anticipate that our field sales managers will devote a significant portion of their time and effort to the reorganization of the sales territories and training of the new sales representatives. It is also important to note that we believe we have sufficient capital resources to execute our fiscal 2009 plan."

In order to efficiently manage the growth of the U.S. sales organization, Uroplasty also announced today the promotion of Bi
'/>"/>

SOURCE Uroplasty, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Uroplasty, Inc. Reports Presentations of Urgent(R) PC Studies at the 2008 Society of Urologic Nurses and Associates Annual Symposium
2. Uroplasty to Present at ROTH Capital Partners 20th Annual OC Growth Stock Conference
3. Uroplasty Expands Marketing Program for Urology Practices
4. Uroplasty, Inc. Announces Pricing of a Public Offering of Its Common Stock
5. Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter
6. Uroplasty to Host Second Quarter Conference Call on November 1
7. Uroplasty, Inc. Announces Filing of Registration Statement for Offering of Common Stock
8. STAAR Surgical Plans Major Presence at ASCRS
9. Medicare Advantage Plans Have New, Better Way to Access CMS Data
10. Ohio Association of Health Plans Announces New Officers
11. Community First Health Plans Selects TCS Healthcare Technologies Care Management Software System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... A Northwestern University synthetic biology team has created ... create programmable therapeutics that could travel the body ... disease. , Engineering cell-based, biological devices that monitor ... in clinical synthetic biology. However, no existing technology ... a patient,s physiological state and respond in a ...
(Date:4/17/2014)... as many as 10 million older Americans suffer from ... isolation. , However, new research a project that ... for six years found that Internet use among ... more than 30 percent. , "That,s a very strong ... of telecommunication, information studies and media who led the ...
(Date:4/17/2014)... By discovering a new mechanism that allows blood to ... UC Irvine and the Salk Institute have opened the ... stroke-induced brain damage. , A complex and devastating neurological ... primary reason for disability in the U.S. The blood-brain ... blood-borne material into the brain, causing the permanent deficits ...
(Date:4/17/2014)... An international team led by researchers at UC Davis ... plays a key role in cell division, also boosts ... the first time the complex has been shown to ... B1/Cdk1 an excellent target to control cellular energy production, ... was published online today in the journal Developmental ...
(Date:4/17/2014)... and their partners have found that their proprietary microbicide ... of multiple sexually transmitted infections (STIs) in both the ... 2 (HSV-2), and human papillomavirus (HPV). The USAID-funded study ... effective against multiple strains of HIV, and has a ... viruses of at least eight hours prior to exposure. ...
Breaking Medicine News(10 mins):Health News:Building 'smart' cell-based therapies 2Health News:Internet use can help ward off depression among elderly 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
... of the University of Pennsylvania reported today that students ... activity are less likely to smoke than their classmates. ... participation extends at least three years beyond graduation. The ... the same level of protection from school sports as ...
... SATELLITE FEED: ... 6:30 PM - 6:45 PM ET ... C-Band ... Downlink Freq: 3980 Horizontal NEWS: Football Legend John Madden ...
... Created by Hospitals from Around the Country Appeal to the ... Contest to Win a Free MRI, MALVERN, Pa., Dec. 6 ... community, but can,t seem to find the time,now,s your chance to ... click of your mouse! The video posting period in Siemens first-ever,"Win ...
... SAN DIEGO, Dec. 6 Neurocrine Biosciences,Inc. (Nasdaq: ... has closed its sale,and leaseback agreement with Veralliance ... by Neurocrine for the properties was,$109 million. Concurrently ... its corporate headquarters for a 12 year term, ...
... on Christmas ... harmony, CINCINNATI, Dec. 6 As they,re searching the ... toys they,think are safe, now parents have a new worry: ... because the unsafe toy they wanted,isn,t under the tree., ...
... Dec. 6 Dr. Belinda Tsao-Nivaggioli,Chief Executive Officer ... http://www.avicenagroup.com ) will be featured in an exclusive ... at 5 p.m. EST. The interview,will be posted ... on December 10., The interview will cover ...
Cached Medicine News:Health News:Participation in organized high school activities lowers risk of smoking 3 years after graduation 2Health News:Participation in organized high school activities lowers risk of smoking 3 years after graduation 3Health News:The Polls are Open! America Votes to Decide Which Hospital is the Most Deserving of Siemens' Newest MRI Technology 2Health News:The Polls are Open! America Votes to Decide Which Hospital is the Most Deserving of Siemens' Newest MRI Technology 3Health News:Neurocrine Announces Closing of $109 Million Sale and Leaseback Agreement for its Real Estate Assets 2Health News:Concern Over Toy Safety and Disappointed Kids Impacts Holidays for Parents 2Health News:Concern Over Toy Safety and Disappointed Kids Impacts Holidays for Parents 3Health News:WallSt.net Announces Upcoming Interview With CEO of Avicena Group 2
(Date:1/14/2014)... 2014 NineSigma , Inc., the leading innovation ... Leadership Summit , May 14-16, 2014 at the Global ... . This is the premier ... breakthrough achievements through open innovation. Participants will learn how ...
(Date:1/14/2014)... PORT WASHINGTON, New York , January 14, ... the leading provider of Closed System Transfer Devices (CSTD) for hazardous drugs, ... sales growth for the fourth straight year.   ... of exposure for pharmacy technicians, pharmacists, nurses and ...
(Date:1/14/2014)... FRANCISCO , Jan. 14, 2014 Spark Therapeutics , ... for its most advanced clinical program, a Phase 3 study for ... gene. Spark,s CEO, Jeffrey D. Marrazzo , is presenting this ... Healthcare Conference in San Francisco . Marrazzo said ...
Breaking Medicine Technology:Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4Equashield's Sales Grow by 60% in 2013 2Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness 2Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness 3
... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) ... officials in FDA,s Office of New Drugs (OND), the ... a cardiovascular outcomes trial (CVOT) for Contrave® that would ... 2011. Orexigen believes that these design requirements are reasonable ...
... CLEVELAND, Sept. 20, 2011 Dr. Melisa Estes, who is ... suffer from chronic knee pain. She recently began incorporating a ... nerve stimulation, also known as TENS, sends electrical stimulation to ... signals from reaching the brain, and that reduces pain. ...
Cached Medicine Technology:Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 2Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 3Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 4Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 5Knee Pain Control - No Drugs - Doctor Used 2
The Panorama Central Station includes bi-directional communication with Datascope bedside monitors, optional 72 hours of disclosure and a touch screen user interface....
... These specialty Eraser instruments have ... surgeon with the right tool for ... introduced a series of 25 gauge ... provide discrete treatment of target tissues ...
... specialty Eraser instruments have been designed ... the right tool for situations requiring ... series of 25 gauge intraocular, bipolar, ... treatment of target tissues for fine-tip ...
Developed in a Microsoft Windows environment, MedInformatix provides physician practices a Computerized Patient Record (CPR) with a Practice Management System (PMS) that is both integrated and design...
Medicine Products: